Daily Maverick on MSN22m
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding ...
Daily Maverick on MSN55m
US funding freeze puts vital tuberculosis research at risk as global health crisis looms
One of the many projects that received termination letters is the Smart4TB programme. The project, coordinated by Johns ...